Business · 03/10/2017Updated: 10/17/2026 · 1 min read
FDA Announces Public Meeting of Endocrinologic and Metabolic Drugs Advisory Committee
Summary
The FDA is hosting a public meeting of its Endocrinologic and Metabolic Drugs Advisory Committee to gather input on regulatory issues, and is seeking public comments on the matter.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →